Screening and litigation. The rate of interval cancers is too high
- PMID: 10999917
- PMCID: PMC1127871
Screening and litigation. The rate of interval cancers is too high
Comment on
-
Screening for breast and cervical cancer as a common cause for litigation. A false negative result may be one of an irreducible minimum of errors.BMJ. 2000 May 20;320(7246):1352-3. doi: 10.1136/bmj.320.7246.1352. BMJ. 2000. PMID: 10818006 Free PMC article. No abstract available.
References
-
- Woloshin S, Schwartz LM, Byram SJ, Sox HC, Fischoff B, Welch HG. Women's understanding of the mammographic screening debate. Ann Intern Med. 2000;160:1434–1440. - PubMed
-
- Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997;127:966–972. - PubMed